3D Global Biotech Inc. (TPEX:6808)

3D Global Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,141	5,131	1,088	1,498	2,143	2,645
Market Cap Growth	371.49%	371.49%	-27.35%	-30.09%	-18.98%	-
Enterprise Value	3,522	4,797	915	1,295	1,901	2,368
Last Close Price	53.20	66.80	19.19	26.58	39.16	48.33
PE Ratio	40.92	55.95	-	-	-	-
PS Ratio	15.59	19.31	52.74	109.79	193.46	199.42
PB Ratio	4.58	5.67	3.71	4.40	5.50	5.89
P/TBV Ratio	5.07	6.28	5.69	6.70	9.03	9.44
P/FCF Ratio	277.74	344.12	-	-	-	-
P/OCF Ratio	210.72	261.08	-	-	-	-
EV/Sales Ratio	13.26	18.05	44.33	94.89	171.68	178.57
EV/EBITDA Ratio	31.93	45.85	-	-	-	-
EV/EBIT Ratio	39.80	54.20	-	-	-	-
EV/FCF Ratio	236.22	321.70	-	-	-	-
Debt / Equity Ratio	0.09	0.09	0.04	0.05	0.06	0.05
Debt / EBITDA Ratio	0.77	0.77	-	-	-	-
Debt / FCF Ratio	5.69	5.69	-	-	-	-
Asset Turnover	0.39	0.39	0.06	0.03	0.02	0.03
Inventory Turnover	17.14	17.14	4.41	5.14	9.16	7.15
Quick Ratio	15.75	15.75	6.34	10.41	15.71	23.46
Current Ratio	15.93	15.93	6.63	10.71	16.04	23.64
Return on Equity (ROE)	15.31%	15.31%	-18.28%	-18.37%	-14.24%	-10.22%
Return on Assets (ROA)	8.12%	8.12%	-11.30%	-10.41%	-8.57%	-6.36%
Return on Capital (ROIC)	8.55%	8.55%	-11.88%	-10.78%	-8.83%	-6.54%
Return on Capital Employed (ROCE)	9.00%	9.00%	-	-	-	-
Earnings Yield	2.21%	1.79%	-5.33%	-4.48%	-2.79%	-1.81%
FCF Yield	0.36%	0.29%	-2.98%	-2.36%	-1.81%	-0.88%
Dividend Yield	1.02%	0.79%	-	-	-	-
Buyback Yield / Dilution	-26.08%	-26.08%	-2.32%	-1.69%	-0.77%	-6.02%
Total Shareholder Return	-25.06%	-25.28%	-2.32%	-1.69%	-0.77%	-6.02%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.